The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. Scientists say this ...

The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.

Needham upgraded Gilead Sciences (NASDAQ:GILD) to Buy from Hold on Friday, citing a physical survey to suggest that the ...

The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...

HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers ...

Northwell Health is now offering a new injection that promises to reduce the risk of HIV and AIDS. Doctors say it will combat ...

Similarly, Gilead has provided nearly $35.8 million in total philanthropic support for Black women-led and/or Black ...

DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...

Chicago-area groups that support LGBTQ+ individuals are navigating an uncertain landscape while bracing for federal funding ...

Amid rising HIV/AIDS cases, Meghalaya to mandate pre-marital testing, starting in East Khasi Hills, citing sexual ...

Arizona organizations are working hard to provide testing and education for HIV/AIDS programs, but despite medical ...

A federal judge extended a block on an Idaho law that uses an applicant’s immigration status to determine whether they’re ...